Dr. Eslam El Berry is a Global Safety Senior Manager at Amgen with over 24 years of experience in the pharmaceutical and healthcare industry, including more than 18 years in pharmacovigilance. He currently leads safety activities across the Middle East and Africa region for Amgen, where he is recognized as a key safety responsible person, ensuring compliance with global standards and local regulatory requirements.

Dr. Eslam has built a distinguished career across leading multinational organizations, including Amgen, Pfizer, and Takeda, working across diverse markets in the Middle East and Africa. Throughout his career, he has played a pivotal role in shaping pharmacovigilance systems, strengthening regulatory compliance frameworks, and driving operational excellence in safety processes.

He is widely recognized as a subject matter expert in pharmacovigilance, leading global and regional initiatives, including risk management programs, safety process optimization, and audit and inspection readiness. Eslam has also been actively engaged with health authorities and has been invited multiple times to speak at pharmacovigilance conferences, contributing to the advancement of the safety landscape in the region.

A strong advocate for patient safety, Dr. Eslam is passionate about building high-performing teams and fostering a culture of trust, collaboration, and continuous development. His leadership has been instrumental in mentoring teams, driving innovation, and enhancing the overall quality of safety operations.

Dr. Eslam holds a Master’s degree in Pharmacovigilance and Pharmacoepidemiology from the University of Bordeaux, France, and brings a strategic, patient-focused approach to advancing drug safety and public health